TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant ...

VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for ...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 FDA’s decision follows positive Phase 1 results for GT-02287 in both healthy ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...

Seam makes it easy to integrate IoT devices with your applications. This is an official SDK for the Seam API. Please refer to the official Seam Docs to get started. The SDK is fully tree-shakeable and ...

Keep the news in the Wayback Machine. Sign Fight for the Future's letter. Please Don't Scroll Past This Can you chip in? The Internet Archive partners with libraries, archives, and institutions across ...

This library serves as a comprehensive reference implementation of MessagePack for JavaScript with a focus on accuracy, compatibility, interoperability, and performance. Additionally, this is also a ...

In many sexually dimorphic species, a mechanism is required to ensure equivalent levels of gene expression from the sex chromosomes. In mammals, such dosage compensation is achieved by X-chromosome ...

Secure Ad Serving (HTTPS): All third-party served creatives and their components (images, stylesheets, JavaScript, tracking pixels, etc.) must be secure (HTTPS) to ensure compliance and correct ...